- Exclusive rights for the development and commercialization of DWP213388 in the global market to V...
SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- The research results of Daewoong Pharmaceutical'...
- 'Daewoong Pharmaceutical enters research collaboration to discover a novel small molecule to tar...
* Submitted an NDA to Indonesia, Philippines and Thailand * Signed the export contract in Brazil...
- Hitting a record high sale with business profits of KRW 106 billion and net profits ofKRW 80.1 bi...
- Evaluation of Bersiporocin's safety and efficacy against a total of 102 patients over 24 weeks -...
* Daewoong Pharmaceutical to receive up to $76M upfront and development milestone payment plus a...
"Expected to change GERD drug market landscape" * Application for product approval of Fexuclue, ...
* Delivers new drug for two consecutive years by obtaining product license on "Envlo", Korea's 36...
* Nabota exports grew significantly, achieving a 93.3% growth YOY, and overall revenue topsKRW 40...
* Highly anticipated to be an effective therapeutic for its excellent efficacies in reducing bloo...
* Embarking on a successful journey of exporting its home-grown product technology toNorth Americ...
- Daewoong Pharmaceutical Co., Ltd. achieved 293.8 billion won in sales and 33.6 billion won in op...
* US Food and Drug Administration (FDA) fast-tracks idiopathic pulmonary fibrosis treatment DWN1...
- U.S. Food and Drug Administration (FDA) approved the IND for the phase 2 clinical trial for patie...
- Marked sales of KRW 272.2 billion and operating profit of KRW 26.8 billion - Reported record-high...
* HanAll Biopharma and Daewoong Pharmaceutical invest in the broad potential of Turn Biotechnolog...
We are advised by HanAll Biopharma and Daewoong Pharmaceutical that journalists and other readers s...
- From Last February to mid-March, NDA has been submitted to each country sequentially - Daewoong ...
SEOUL, South Korea, Feb. 25, 2022 /PRNewswire/ -- Daewoong Pharmaceutical (Daewoong) announced the ...